CLINICAL_TRIALS
trial_result
· 2016-01-20
Clinical Trial Update: The Safety Research of Freeze-dried Rabies Vaccine(MRC-5 Cell) in Chinese Humans [Phase 1]
Summary
A Phase 1 trial evaluating the safety of a freeze-dried rabies vaccine derived from MRC-5 cells in healthy Chinese adults has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Beijing Center for Disease Control and Prevention | Conditions: Rabies, Healthy | Phase 1 | Status: COMPLETED